Keytruda Intravenous Infusion 100 ㎎

2026-11-03

Official in charge of disbursement of the procuring entity : Hirotoshi Matsui, Director, National Hospital Organization Tokyo National Hospital Classification of the products to be procured : Nature and quantity of the products to be purchased : Keytruda Intravenous Infusion 10 ㎎ Fulfillment period : From November 1, 202 through September 30, 202 Delivery place : National Hospital Organization Tokyo National Hospital Qualification for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall : not come under Article of the Regulation concerning Contract for National Hospital Organization (NHO). Furthermore, minors, Person under Conservatorshi or Person under Assistance that obtained the consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause ; not come under Article of the Regulation concerning Contract for NHO ; have Grade A, B, C or D in "Sales of products" for participating in tenders by Ministry of Health, Labour and Welfare (Single qualification for every ministry and agency) in Kanto-Koshinetsu Region ; Be a person who has license of pharmaceutical sales business based on Pharmaceutical Affairs Law ; Among the items shown in the "Pharmaceuticals Procurement List" issued separately, those who bid on narcotics are those who have a license for narcotics and drug shelf wholesale business based on the provision of Article paragraph of the Act on Control of Psychotropi Drugs about ; Time-limit for tender : : 0 P.M. October 20, 202 Contact point for the notice : Masafumi Odajima, Director, Accounting Division, National Hospital Organization Tokyo National Hospital, 3-1- Takeoka Kiyose-shi Tokyo 204-8585, Japan. TEL 042-491-211 ext. 2250

Japan

2026-09-18